[New drugs in antitubercular therapy].
D000636:Aminosalicylic Acids / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use*; D004977:Ethambutol / Q000627:therapeutic use; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D012316:RNA Nucleotidyltransferases / Q000037:antagonists & inhibitors; D012293:Rifampin / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000636:Aminosalicylic Acids; D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents; D004977:Ethambutol; D012316:RNA Nucleotidyltransferases; D007538:Isoniazid; D012293:Rifampin
Nouveaux médicaments dans la thérapeutique antituberculeuse.